Venous thromboembolism in children: Rivaroxaban effective and safe even with extended use. Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer. Treatment or prevention of thrombosis poses an additional challenge in everyday clinical practice. A therapy using the active ingredient rivaroxaban specifically tailored to children […]
Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrolment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, […]
AF Association Healthcare Pioneers Report: Showcasing best practice in AF 2021: Today, to mark the start of Global AF Aware Week 2020, the AF Association has published its annual Healthcare Pioneers Report. Each year, the Healthcare Pioneers Report showcases the most innovative approaches to detecting and managing atrial fibrillation (AF). The aim is to provide models […]
The Top Journal Lancet Haematology recently published an international trial on a blood thinner to treat blood clots in children. Principal investigator was Christoph Male from the Department of Paediatrics and Adolescent Medicine, MedUni Vienna. He was now invited by Lancet Haematology to write a ‘Debate Article’ to give his view on the usefulness of […]
Read More… from Are clinical trials of anticoagulation feasible in children?